देश: यूनाइटेड किंगडम
भाषा: अंग्रेज़ी
स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ciclesonide
Mawdsley-Brooks & Company Ltd
R03BA08
Ciclesonide
80microgram/1dose
Pressurised inhalation
Inhalation
No Controlled Drug Status
Valid as a prescribable product
BNF: 03020000
PATIENT INFORMATION LEAFLET ALVESCO ® 80 INHALER (ciclesonide) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. Your medicine is available by using the above name but will be referred to as Alvesco throughout the leaflet. Alvesco Inhaler is also available in other strengths. WHAT IS IN THIS LEAFLET: 1. What Alvesco is and what it is used for 2. What you need to know before you use Alvesco 3. How to use Alvesco 4. Possible side effects 5. How to store Alvesco 6. Contents of the pack and other information 1. WHAT ALVESCO IS AND WHAT IT IS USED FOR WHAT ALVESCO IS: Alvesco is a clear and colourless aerosol spray for you to breathe in through your mouth and into your lungs. It is a Preventer medication (corticosteroid) that has to be taken every day and which becomes active only after it has been inhaled into your lungs. The ACTIVE INGREDIENT in this medicine is ciclesonide. (For the OTHER INGREDIENTS, see Section 6). WHAT ALVESCO IS USED FOR: This medicine is prescribed to control persistent asthma in adult and adolescent patients (12 years old and more). It helps you to breathe more easily by decreasing the symptoms of your asthma and by lessening the chances of an asthma attack. The effect builds up over a period of time, so this medicine needs to be taken every day, even when you are feeling well. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE ALVESCO DO NOT USE ALVESCO if you are allergic (hypersensitive) to ciclesonide or any of the other ingredients of this medicine (listed in section 6). TAKE SPECIAL CARE WITH ALVESC पूरा दस्तावेज़ पढ़ें
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Alvesco ® 80 Inhaler 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 actuation (delivered dose from the mouthpiece) contains 80 micrograms of ciclesonide. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pressurised inhalation, solution Clear and colourless 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment to control persistent asthma in adults and adolescents (12 years and older). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The medicinal product is for inhalation use only. Posology Dosing recommendation for adults and adolescents: The recommended dose of Alvesco is 160 micrograms once daily, which leads to asthma control in the majority of patients. In patients with severe asthma and while reducing or discontinuing oral corticosteroids a higher dose of up to 640mcg/day (given as 320mcg twice daily) may be used (see section 5.1) Patients should be given a dose of inhaled ciclesonide which is appropriate to the severity of their disease. Symptoms start to improve with Alvesco within 24 hours of treatment. Once control is achieved, the dose of Alvesco should be individualised and titrated to the minimum dose needed to maintain good asthma control. Dose reduction to 80 micrograms once daily may be an effective maintenance dose for some patients. Alvesco should preferably be administered in the evening although morning dosing of Alvesco has also been shown to be effective. The final decision on evening or morning dosing should be left to the discretion of the physician. Patients with severe asthma are at risk of acute attacks and should have regular assessments of their asthma control including pulmonary function tests. Increasing use of short-acting bronchodilators to relieve asthma symptoms indicates deterioration of asthma control. If patients find that short-acting relief bronchodilator treatment becomes less effective, or they need more inhalations than usual, medical attention must be sought. In this situation, patien पूरा दस्तावेज़ पढ़ें